Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia
Conditions
- Chronic Lymphocytic Leukemia
Interventions
- DRUG: Bendamustine
- BIOLOGICAL: Rituximab
Sponsor
German CLL Study Group
Collaborators